ACAD - ACADIA Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACAD is currently covered by 15 analysts with an average price target of $30.36. This is a potential upside of $6.99 (15.88%) from yesterday's end of day stock price of $26.2.

ACADIA Pharmaceuticals's activity chart (see below) currently has 413 price targets and 334 ratings on display. The stock rating distribution of ACAD is 69.23% BUY, 28.21% HOLD and 2.56% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.25% with an average time for these price targets to be met of 251.23 days.

Highest price target for ACAD is $40, Lowest price target is $17, average price target is $30.36.

Most recent stock forecast was given by TAZEEN AHMAD from BAML on 30-Jun-2026. First documented stock forecast 06-May-2013.

Best performing analysts who are covering ACAD - ACADIA Pharmaceuticals:

Robert Leboyer Cory Kasimov Ritu Baral Alan Carr Thomas Wei Joel Beatty Jason Butler

Currently out of the existing stock ratings of ACAD, 27 are a BUY (69.23%), 11 are a HOLD (28.21%), 1 are a SELL (2.56%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Jun-2026

$30

$4.03 (15.52%)

$29

8 days ago
(30-Jun-2026)

10/13 (76.92%)

$4.7 (18.58%)

275

Buy Since 21-Oct-2025

$35

$9.03 (34.77%)

$32

9 days ago
(29-Jun-2026)

0/4 (0%)

$9.8 (38.89%)

Buy Since 01-Mar-2024

$34

$8.68 (34.28%)

$31

4 months 4 days ago
(04-Mar-2026)

8/15 (53.33%)

$10.61 (45.36%)

113

Buy Since 26-Nov-2019

$35

$9.68 (38.23%)

$34

4 months 12 days ago
(26-Feb-2026)

7/20 (35%)

$10.36 (42.05%)

274

Buy Since 23-Jun-2025

$30

$4.68 (18.48%)

$31

4 months 12 days ago
(26-Feb-2026)

0/6 (0%)

$5.36 (21.75%)

Show more analysts

Please expand the browser size to see the chart

What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?

On average it took 251.23 days on average for the stock forecasts to be realized with a an average price target met ratio 57.25

Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?

ROBERT LEBOYER

Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?

Robert Leboyer works at NOBLE CAPITAL and has 4 price targets and 3 ratings on ACAD

Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?

Alan Carr with highest potential upside - $38.26

Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?

Salveen Richter with lowest potential downside - -$8.97

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?